BHVN · Biohaven Ltd.

$14.64 -0.21 (-1.41%) At close · Aug 14

Market Cap

$2.21B

151.04M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vlad Coric	Chief Executive Officer	$885,000	$1,161,563	—	$8,415,633	—	$16,842	$10,479,038
Matthew Buten	Chief Financial Officer	$573,300	$501,638	—	$2,945,471	—	$22,926	$4,043,335
Bruce Car	Chief Scientific Officer	$515,567	$451,121	—	$2,945,471	—	$22,919	$3,935,078
Kimberly Gentile	Senior Vice President, Clinical Operations	$489,306	$385,329	—	$2,945,471	—	$18,865	$3,838,971

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vlad Coric	Chief Executive Officer	$840,000	$1,102,500	—	$4,860,630	—	$16,059	$6,819,189
Matthew Buten	Chief Financial Officer	$551,250	$482,388	—	$1,701,221	—	$20,778	$2,755,637
Bruce Car	Chief Scientific Officer	$489,850	$385,757	—	$1,701,221	—	$7,420	$2,584,248
Kimberly Gentile	Senior Vice President, Clinical Operations	$470,487	$370,509	—	$1,701,221	—	$17,656	$2,559,873

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vlad Coric	Chief Executive Officer	$200,000	$1,050,000	—	$4,720,774	—	$705	$5,971,479
Matthew Buten	Chief Financial Officer	$131,250	$413,438	—	$1,490,771	—	$1,015	$2,036,473
Bruce Car	Chief Scientific Officer	$121,250	$160,100	—	$1,490,771	—	$1,787	$1,773,908

Executive changes

Person	Role	Change	Effective	Filed
John Yetimoglu	director	Appointed	2026-08-06	2026-08-07
David Pirman, Ph.D.	Executive Vice President and Head of Discovery	Appointed	2026-07-13	2026-07-09
Bruce Car, Ph.D.	Chief Innovation Officer	Appointed	2026-07-13	2026-07-09
Kishan Mehta	director	Appointed	2022-09-28	2022-10-03
Vladimir Coric	director	Appointed	2022-09-28	2022-10-03
Matthew Buten	Chief Financial Officer	Appointed	2022-09-28	2022-10-03
John Childs	director	Appointed	2022-09-28	2022-10-03
Gregory Bailey	director	Appointed	2022-09-28	2022-10-03
Julia Gregory	director	Appointed	2022-09-28	2022-10-03
Robert Hugin	director	Appointed	2022-09-28	2022-10-03
Michael T. Heffernan	director	Appointed	2022-09-28	2022-10-03
Irina Antonijevic	director	Appointed	2022-09-28	2022-10-03

Key facts CIK 1935979 CUSIP G1110E107 13F (30d) 271 filings 269 filers Visit website Investor relations